Literature DB >> 28395832

Co-trimoxazole for HIV-exposed uninfected infants.

Ceri Evans1, Andrew J Prendergast2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28395832     DOI: 10.1016/S2214-109X(17)30147-X

Source DB:  PubMed          Journal:  Lancet Glob Health        ISSN: 2214-109X            Impact factor:   26.763


× No keyword cloud information.
  4 in total

Review 1.  A Meta-analysis Assessing Diarrhea and Pneumonia in HIV-Exposed Uninfected Compared With HIV-Unexposed Uninfected Infants and Children.

Authors:  Alana T Brennan; Rachael Bonawitz; Christopher J Gill; Donald M Thea; Mary Kleinman; Lawrence Long; Caitryn McCallum; Matthew P Fox
Journal:  J Acquir Immune Defic Syndr       Date:  2019-09-01       Impact factor: 3.731

2.  Peripheral blood mononuclear cell transcriptomes reveal an over-representation of down-regulated genes associated with immunity in HIV-exposed uninfected infants.

Authors:  Zaneta D Musimbi; Martin K Rono; James R Otieno; Nelson Kibinge; Lynette Isabella Ochola-Oyier; Etienne Pierre de Villiers; Eunice W Nduati
Journal:  Sci Rep       Date:  2019-12-02       Impact factor: 4.379

3.  Differential expression of Fas receptors (CD95) and Fas ligands (CD95L) in HIV infected and exposed uninfected children in Cameroon versus unexposed children.

Authors:  Béatrice Dambaya; Céline Nguefeu Nkenfou; Georgia Ambada; George Mondinde Ikomey; Linda Mekue Mouafo; Nicole Ngoufack; Elvis Ndukong Ndzi; Georges Této; Aubin Nanfack; Nelson Sonela; Joseph Fokam; Njiokou Flobert; Vittorio Colizzi; Alexis Ndjolo
Journal:  Pan Afr Med J       Date:  2019-09-18

4.  The prevalence and clinical characteristics of pertussis-associated pneumonia among infants in Botswana.

Authors:  Bahaa Abu-Raya; David M Goldfarb; Marek Smieja; Kathy Luinstra; Melissa Richard-Greenblatt; Andrew P Steenhoff; Kristen A Feemster; Tonya Arscott-Mills; Coleen K Cunningham; Samir S Shah; Mohamed Zaakir Patel; Matthew S Kelly; Manish Sadarangani
Journal:  BMC Pediatr       Date:  2019-11-16       Impact factor: 2.125

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.